OpenEvidence
CompanyOpenEvidence closed a $75 million Series A round in February 2025 led by Sequoia Capital, which valued the company at $1 billion. The platform enables verified physicians to access referenced, point‑of‑care medical information and is used daily by more than 40 percent of U.S. doctors across over 10,000 medical facilities.
Date
Feb 20, 2025
Category
healthcare
Lead investor
Sequoia
Stage
Series A
Size
$75M
Two Sigma Ventures
Notable Capital
Gradient Ventures
Insight Partners
Emergence Capital
Radical Ventures
Forerunner Ventures
General Catalyst
GV
Acrew Capital
Eclipse